<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-939
Date of Submission: 2024-12-08

This report was submitted by a Nurse from Phillips, Webster and Williams Medical Center concerning patient ANON-PX-7263. The subject is an adult male with a significant medical history including anxiety, chronic kidney disease, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole (Proton-pump inhibitor) administered via the Subcutaneous route at a dosage of 78mg, initiated on 2024-11-21 for Gastroesophageal reflux disease and discontinued on 2024-12-03.

On approximately 2024-11-28, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Somnolence, Dizziness, Headache. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Somnolence was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Fatal'. The Dizziness was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Headache was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed unit and advised across. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 10 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Citizen low recognize policy man she kitchen.</data>
report_id: ADR-2024-939
report_date: '2024-12-08'
patient_details:
  patient_id: ANON-PX-7263
  gender: Male
  relevant_history:
  - anxiety
  - chronic kidney disease
  - hypertension
suspected_drugs:
- drug_name: Omeprazole
  dosage: 78mg
  route_of_administration: Subcutaneous
  start_date: '2024-11-21'
  indication_for_use: Gastroesophageal reflux disease
  drug_class: Proton-pump inhibitor
  end_date: '2024-12-03'
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2024-11-28'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
- symptom_name: Somnolence
  onset_date: '2024-11-28'
  severity: Mild
  outcome: Fatal
  intervention_required: true
- symptom_name: Dizziness
  onset_date: '2024-11-28'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: false
- symptom_name: Headache
  onset_date: '2024-11-28'
  severity: Severe
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed unit and advised across.
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 10
reporting_facility: Phillips, Webster and Williams Medical Center
reporter_type: Nurse
notes: Citizen low recognize policy man she kitchen.
